Last reviewed · How we verify
LHRHA or Surgical Castration — Competitive Intelligence Brief
phase 3
LHRH agonist / Surgical intervention
LHRH receptor (for LHRH agonist component)
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
LHRHA or Surgical Castration (LHRHA or Surgical Castration) — University of Sydney. LHRH agonists suppress testosterone production by desensitizing the pituitary gland, while surgical castration directly removes the testes to eliminate androgen production.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LHRHA or Surgical Castration TARGET | LHRHA or Surgical Castration | University of Sydney | phase 3 | LHRH agonist / Surgical intervention | LHRH receptor (for LHRH agonist component) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (LHRH agonist / Surgical intervention class)
- University of Sydney · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LHRHA or Surgical Castration CI watch — RSS
- LHRHA or Surgical Castration CI watch — Atom
- LHRHA or Surgical Castration CI watch — JSON
- LHRHA or Surgical Castration alone — RSS
- Whole LHRH agonist / Surgical intervention class — RSS
Cite this brief
Drug Landscape (2026). LHRHA or Surgical Castration — Competitive Intelligence Brief. https://druglandscape.com/ci/lhrha-or-surgical-castration. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab